drugset / Trial / NCT05576818

Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease

NCT05576818 ↗

Phase 3 Recruiting 66 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to investigate the possible efficacy and safety of synbiotic preparation of Lactobacillus acidophilus probiotic with prebiotic fibers as an adjuvant therapy in the treatment of Parkinson's disease

Timeline

Start
2022-06-30
Primary completion
2025-06
Completion
2025-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator synbiotic Other / unclassified 2 unknown —

Indications